Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis"

Stroke. 2017 Jun;48(6):e148. doi: 10.1161/STROKEAHA.117.017375. Epub 2017 Apr 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Administration, Oral
  • Anticoagulants
  • Atrial Fibrillation
  • Dabigatran*
  • Humans
  • Pyridones
  • Rivaroxaban
  • Stroke
  • Warfarin*

Substances

  • Anticoagulants
  • Pyridones
  • Warfarin
  • Rivaroxaban
  • Dabigatran